Number of Shares
12,049.00
Current Holdings Value*
$179,650.00
% of Portfolio
1.84%
Total Estimate Gain
$22,315.26
% of Total Estimate Gain
10.40%

PGIM Jennison Small-Cap Core Equity Fund's Arcutis Biotherapeutics Inc Holding Summary

As of 2025-04-30, PRUDENTIAL INVESTMENT PORTFOLIOS 2 held 12,049.00 shares of Arcutis Biotherapeutics Inc(ARQT), totaling $179,650.00. This investment constitutes 1.84% of their stock portfolio, and PRUDENTIAL INVESTMENT PORTFOLIOS 2 now holds 0.01% of the outstanding Arcutis Biotherapeutics Inc(ARQT) stock.

The initial trade took place in 2022Q4. And since then PGIM Jennison Small-Cap Core Equity Fund has made 8 purchases of ARQT, at an average price of $11.98, for a total of 17,913.00 shares. In addition, there have been 3 sales at an average price of $8.60 for 5,864.00 shares. Based on historical transaction data and ARQT's current price of $15.48, PGIM Jennison Small-Cap Core Equity Fund's estimated gain on his ARQT holdings is $22,315.26, reflecting a 10.40% gain to date.

PGIM Jennison Small-Cap Core Equity Fund ARQT ($15.48) Holding Chart

PGIM Jennison Small-Cap Core Equity Fund ARQT ($15.48) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1